WHO ICTRP trial
A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Assess the…
ACTRN12612000092897 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12612000092897 |
|---|---|
| Public title | A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Assess the Efficacy and Safety of 12 Weeks of Satiereal(R) Supplementation on Food Cravings and Preferences, Body Composition, Satiety and Appetite Regulatory Hormones, and Clinical Safety Markers in Overweight/Obese Individuals |
| Scientific title | A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Assess the Efficacy and Safety of 12 Weeks of Satiereal(R) Supplementation on Food Cravings and Preferences in Overweight/Obese Individuals |
| Primary sponsor | Matthew Cooke |
| Secondary sponsors | Christos Stathis |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Australia |
| Conditions | snacking behavior;obesity; snacking behavior obesity;Diet and Nutrition - Obesity |
| Interventions | Satiereal is a single patented C sativus stigma extract (Inoreal Ltd, Plerin, France). Satiereal is notified and registered as food supplement in France by the National Trade and Fraud Authority (Direction Generale de la Concurrence, de la… |
| Registration date | Jan 18, 2012 |
| Target size | 72 |
| Secondary IDs | 'Nil' |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: